JAC Advance Access originally published online on July 8, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy 2004 54(2):435-440; doi:10.1093/jac/dkh343
JAC vol.54 no.2 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales
1 Laboratory of Enteric Pathogens, Health Protection Agency, Specialist and Reference Microbiology Division, 61 Colindale Avenue, London NW9 5HT, UK; 2 National Public Health Service, Bangor, Gwynedd LL57 2PW, Wales, UK
* Corresponding author. Tel: +44-20-8327-6740; Fax: +44-20-8905-9929; Email: robert.owen{at}hpa.org.uk
Objective: Surveillance data on Helicobacter pylori antibiotic susceptibilities in Wales are limited, despite resistance being a key factor in treatment failure. A single-centre survey was undertaken over 3 years to determine local antibiotic resistance rates on isolates from dyspeptic patients in Bangor, Gwynedd (North Wales).
Methods: Susceptibilities were determined for 363 isolates by disc diffusion and the Etest. Isolates were also genotyped (cagA presence and vacA allelic types).
Results: Overall in vitro resistance rates were 24% for metronidazole and 7% for clarithromycin, with 4% resistant to both antibiotics. Resistant strains typically had high MICs of >256 mg/L. Tetracycline resistance was identified in only one isolate whereas no isolates showed resistance to amoxicillin. There was a two-fold increase in resistance over the study period. No gender and age associations with resistance were detected. Resistant and susceptible isolates were genotypically diverse with respect to cagA/vacA type but the vacA s1m2 form was a feature of all clarithromycin-resistant isolates compared with 56% of the susceptible isolates.
Conclusion: Although the overall antibiotic resistance rates of H. pylori from North Wales were low compared with many other regions in Europe, continued surveillance, particularly of high-level resistance (MIC >256 mg/L), is recommended to monitor the effects of the ‘test and treat’ strategy for H. pylori eradication.
Keywords: clarithromycin , metronidazole , dual resistance , surveillance
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. J. Owen and J. Xerry Geographical conservation of short inserts in the signal and middle regions of the Helicobacter pylori vacuolating cytotoxin gene Microbiology, April 1, 2007; 153(4): 1176 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Minami, M. Ohta, T. Ohkura, T. Ando, K. Torii, T. Hasegawa, and H. Goto Use of a Combination of Brushing Technique and the Loop-Mediated Isothermal Amplification Method as a Novel, Rapid, and Safe System for Detection of Helicobacter pylori. J. Clin. Microbiol., November 1, 2006; 44(11): 4032 - 4037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lawson, N. C. Elviss, and R. J. Owen Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales J. Antimicrob. Chemother., August 1, 2005; 56(2): 282 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C Elviss, R. J Owen, A. Breathnach, C. Palmer, and N. Shetty Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000 J. Med. Microbiol., June 1, 2005; 54(6): 567 - 574. [Abstract] [Full Text] [PDF]
|
|